GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $731,000 | -89.0% | 30,579 | -93.3% | 0.00% | -92.3% |
| Q4 2020 | $6,633,000 | -2.2% | 454,283 | -4.9% | 0.01% | -13.3% |
| Q3 2020 | $6,781,000 | +1859.8% | 477,558 | +1931.9% | 0.02% | +1400.0% |
| Q2 2020 | $346,000 | +190.8% | 23,503 | -18.3% | 0.00% | – |
| Q1 2020 | $119,000 | -13.8% | 28,782 | 0.0% | 0.00% | – |
| Q4 2019 | $138,000 | +1.5% | 28,782 | +28.2% | 0.00% | – |
| Q3 2019 | $136,000 | -6.8% | 22,455 | 0.0% | 0.00% | – |
| Q2 2019 | $146,000 | +4.3% | 22,455 | +13.8% | 0.00% | – |
| Q1 2019 | $140,000 | +45.8% | 19,725 | 0.0% | 0.00% | – |
| Q4 2018 | $96,000 | -33.8% | 19,725 | 0.0% | 0.00% | – |
| Q3 2018 | $145,000 | +15.1% | 19,725 | 0.0% | 0.00% | – |
| Q2 2018 | $126,000 | +17.8% | 19,725 | 0.0% | 0.00% | – |
| Q1 2018 | $107,000 | +30.5% | 19,725 | 0.0% | 0.00% | – |
| Q4 2017 | $82,000 | -56.8% | 19,725 | 0.0% | 0.00% | – |
| Q3 2017 | $190,000 | -18.5% | 19,725 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $233,000 | +8.4% | 19,725 | +17.5% | 0.00% | – |
| Q1 2017 | $215,000 | +4.9% | 16,782 | 0.0% | 0.00% | – |
| Q4 2016 | $205,000 | -19.9% | 16,782 | -22.5% | 0.00% | – |
| Q3 2016 | $256,000 | +29.3% | 21,664 | -5.0% | 0.00% | – |
| Q2 2016 | $198,000 | +65.0% | 22,809 | 0.0% | 0.00% | – |
| Q1 2016 | $120,000 | -32.2% | 22,809 | 0.0% | 0.00% | – |
| Q4 2015 | $177,000 | -1.7% | 22,809 | 0.0% | 0.00% | – |
| Q3 2015 | $180,000 | -13.0% | 22,809 | 0.0% | 0.00% | – |
| Q2 2015 | $207,000 | -30.1% | 22,809 | 0.0% | 0.00% | -100.0% |
| Q1 2015 | $296,000 | -4.5% | 22,809 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $310,000 | +51.2% | 22,809 | 0.0% | 0.00% | – |
| Q3 2014 | $205,000 | -33.7% | 22,809 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $309,000 | +36.1% | 22,809 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $227,000 | -25.3% | 22,809 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $304,000 | +9.7% | 22,809 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $277,000 | +17.4% | 22,809 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $236,000 | – | 22,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 500,000 | $6,765,000 | 5.83% |
| Gruss & Co., LLC | 200,000 | $2,706,000 | 3.07% |
| First Light Asset Management, LLC | 150,076 | $2,031,000 | 1.37% |
| Curi RMB Capital, LLC | 1,032,369 | $13,968,000 | 0.88% |
| Camber Capital Management LP | 908,100 | $12,287,000 | 0.80% |
| CADIAN CAPITAL MANAGEMENT, LP | 887,500 | $12,008,000 | 0.36% |
| PARNASSUS INVESTMENTS, LLC | 2,118,127 | $28,658,000 | 0.25% |
| Visium Asset Management, LP | 786,468 | $10,641,000 | 0.16% |
| PUTNAM INVESTMENTS LLC | 5,198,367 | $70,333,000 | 0.15% |
| Capital Impact Advisors, LLC | 13,933 | $189,000 | 0.14% |